DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of ...
Medtronic plcMDT announced the receipt of FDA approval for the Guardian Connect continuous glucose monitoring (CGM) system for diabetes patients between the ages of 14 to 75 years. Notably, the system ...
Exclusive Access to Sugar.IQ Assistant with Watson Offers More Proactive Diabetes Management Featuring our latest predictive algorithms in diabetes care, the Guardian Connect system is the only ...
Medtronic plc. (NYSE:MDT) recently made a major development in the field of diabetes management. The company reached an outcome-based agreement with Blue Cross and Blue Shield of Minnesota in relation ...
Mumbai, January 03, 2019: In a first of its kind collaborative initiative in India between a pharmaceutical and medical device company, Eris Lifesciences, one of the leading players in the chronic ...
DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of its ...
Medtronic plc MDT announced the receipt of FDA approval for the Guardian Connect continuous glucose monitoring (CGM) system for diabetes patients between the ages of 14 to 75 years. Notably, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback